http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#Head http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#assertion http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#provenance http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#pubInfo http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#assertion http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#assertion http://www.w3.org/ns/prov#wasGeneratedBy S&T TWOC project version 1 http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#version http://www.w3.org/ns/prov#value 1 http://www.w3.org/1999/02/22-rdf-syntax-ns#object https://uts.nlm.nih.gov/uts/umls/concept/C0442886 secondary infections http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate http://twoc-nlp-database-server-1:8555/solr/predicates/select?q=TRIPLE_UID:kmvq6bit-TRIPLE-ABSTRACT-9 experience http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C0011777 dexamethasone http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C0030705 patients http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C0441833 group http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C0687744 group http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C1257890 group http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C1442989 standard http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C1548173 standard http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C1561557 group http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C1705428 group http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C1705429 group http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C1947933 care http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C2362566 care http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C2828392 standard http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://uts.nlm.nih.gov/uts/umls/concept/C3272550 standard http://www.w3.org/2000/01/rdf-schema#Triple-UID http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:kmvq6bit-TRIPLE-ABSTRACT-9 kmvq6bit-TRIPLE-ABSTRACT-9 http://www.w3.org/2000/01/rdf-schema#sentence http://www.w3.org/2000/01/rdf-schema#label Thirty-three patients (21.9%) in the dexamethasone group vs 43 (29.1%) in the standard care group experienced secondary infections, 47 (31.1%) vs 42 (28.3%) needed insulin for glucose control, and 5 (3.3%) vs 9 (6.1%) experienced other serious adverse events. http://www.w3.org/2000/01/rdf-schema#triple http://www.w3.org/2000/01/rdf-schema#label Thirty - three patients ( 21.9 % ) in the dexamethasone group vs 43 ( 29.1 % ) in the standard care group experienced secondary infections http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#provenance http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#assertion http://www.w3.org/ns/prov#generatedAtTime 2021-07-25T21:45:49.773306 http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#pubInfo http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#sig http://purl.org/nanopub/x/hasSignature RnTbRncETO8rcPKb0HBPakUVuL0neiEyHGUfEMJ2fykJhGvgukg7SaLYPwNHr3ConoWrBe5EB0wnwNIUY3+KZnVW08+HZdMQT4z48kt1g7KgCezstbdeIyPKN81e+gjPkyWJiKVd3OE0asrdZkUoSILfJHaK1ZQwner7tWg7/ZY= http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os http://www.w3.org/ns/prov#generatedAtTime 2021-07-25T21:45:49.773306 http://purl.org/np/RA0FHkROmDX11eRGOg2zWiFGhL_kXfzSKr9iuXZOzZ1Os http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-8954-0470